Financial disclosures in clinical practice guidelines.
作者信息
Kahn Jeremy M, Rubenfeld Gordon D
出版信息
Crit Care Med. 2010 Aug;38(8):1755-6; discussion 1756-7. doi: 10.1097/CCM.0b013e3181de19d9.
PMID:20647810
Abstract
摘要
相似文献
1
Financial disclosures in clinical practice guidelines.
Crit Care Med. 2010 Aug;38(8):1755-6; discussion 1756-7. doi: 10.1097/CCM.0b013e3181de19d9.
2
Public disclosure of conflicts of interest: moving the policy debate forward.
Arch Intern Med. 2010 Apr 26;170(8):667. doi: 10.1001/archinternmed.2010.27.
3
Doctors and the drug industry: reader feedback.
Am J Med. 2005 Oct;118(10):1176-7; author reply 1177. doi: 10.1016/j.amjmed.2005.02.035.
4
The devil in the detail(ing).
Am J Bioeth. 2010 Jan;10(1):15-7. doi: 10.1080/15265160903460905.
5
Huddle gets it right, most docs don't.
Am J Bioeth. 2010 Jan;10(1):17-9. doi: 10.1080/15265160903441087.
6
The details are in the field.
Am J Bioeth. 2010 Jan;10(1):19-21. doi: 10.1080/15265160903460921.
7
Why academic medical centers should ban drug company gifts to individuals.
Am J Bioeth. 2010 Jan;10(1):13-5. doi: 10.1080/15265160903441061.
8
Response to open peer commentaries on "The pitfalls of deducing ethics from economics: why the Association of American Medical Colleges is wrong about pharmaceutical detailing".
Am J Bioeth. 2010 Jan;10(1):W1-3. doi: 10.1080/15265160903493088.
9
Drug detailers, professionalism, and prudence.
Am J Bioeth. 2010 Jan;10(1):9-10. doi: 10.1080/15265160903441020.
10
Contact with pharmaceutical representatives: where does prudence lead?
Am J Bioeth. 2010 Jan;10(1):11-3. doi: 10.1080/15265160903441046.
Zotero 插件